Etiología y tratamiento | 26 OCT 15

Metrorragia en mujeres premenopáusicas no embarazadas

El sangrado vaginal no programado se produce fuera del período menstrual normal o es secundario al uso de anticonceptivos orales, es una razón común de consulta en atención primaria por las mujeres en edad reproductiva.
11
23
Autor: Dras. Mary Ann Lumsden, Ailsa Gebbie, Cathrine Holland. BMJ 2013;346:f3251
INDICE:  1. Artículo | 2. Referencias
Referencias

1 Warner P, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray G. Referral for menstrual problems: cross sectional survey of symptoms, reasons for referral and management. BMJ 2001;323:24-8.
2 Office for National Statistics. Cancer statistics registrations. Registrations of cancers diagnosed in England 2003. ONS, 2005.
3 Kjerulff KJ, Langenberg P, Seidman JD, Stolley PD, Guzinsi GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1995;41:483-90.
4 Dreisler E, Sorensen S, Ibsen PH, Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol2009;33:102-8.
5 Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981;36:433-45.
6 Harlow BL, Weiss NS, Lafton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 1986;76:399-402.
7 Lee SC, Kaunitz AM, Sanchez-Ramos L, Rhatigan RM. The oncogenic potential of endometrial polyps: a systematic review and meta-analysis. Obstet Gynecol 2010;116:1197-205.
8 Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle throughout life. Int J Fertil 1967;12:77-126.
9 Faculty of Sexual and Reproductive Healthcare Clinical Guidance. Intra-uterine contraception. 2007.
www.fsrh.org/pdfs/CEUGuidanceIntrauterineContraceptionNov07. pdf.
10 Rosenthal AN, Panoskaltsis T, Smith T, Soutter WP. The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding. Br J Obstet Gynaecol 2001;108:103-6.
11 Sahu B, Latheef R, Magd SA. Prevalence of pathology in women attending colposcopy for postcoital bleeding with negative cytology. Arch Gynecol Obstet 2007;276:471-3.
12 Cancer Research UK. CancerStats—Cancer statistics for the UK. 2009. www. cancerresearchuk.org/cancer-info/cancerstats/.
13 Henderson HJ. Why lesbians should be encouraged to have regular cervical screening. J Fam Plann Reprod Health 2009;35:49-52.
14 Royal College of Obstetricians and Gynaecologists. Faculty of Sexual and Reproductive Healthcare clinical guidance. Management of unscheduled bleeding in women using hormonal contraception. 2009.
www.fsrh.org/pdfs/UnscheduledBleedingMay09.pdf.
15 Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 μg versus >30 μg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev 2011;1:CD003989.
16 Endrikat J, Gerlinger C, Plettig K, Wessel J, Schmidt W, Grubb G, et al. A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use. Gynecol Endocrinol 2003;17:107-14.
17 Hickey M, Fraser IS. Clinical implications of disturbances of uterine vascular morphology and function. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:937-51.
18 Szarewski A. Sisters doing it for themselves. J Fam Plann Reprod Health Care ;2009;35:71-2.
19 Oddsson K, Liefels-Fischer B, Wiel-Masson D, de Melo NR, Benedetto C, Verhoeven CHJ, et al. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel: a randomized trial. Hum Reprod 2005;20:557-62.
20 Public Health England. Colposcopy and Programme Management. Guidelines for the NHS cervical screening programme. No 20. 2010:15-6.
www.cancerscreening.nhs.uk/cervical/publications/nhscsp20.html.
21 Public Health England. Clinical practice guidance for the assessment of young women aged 20-24 with abnormal vaginal bleeding. 2010.
www.cancerscreening.nhs.uk/cervical/publications/doh-guidelines-young-women.html.
22 National Institute for Health and Care Excellence. Referral guidelines for suspected cancer. CG27. 2005.
http://publications.nice.org.uk/referral-guidelines-for-suspected-cancer-cg27/guidance.
23 AAGL Practice Report. Practice guidelines for the diagnosis and management of endometrial polyps. Journal of Minimally Invasive Gynaecology 2012;19:3-10.
24 Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ulatrasonography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynaecol Scand 2003;82:493-504.
25 Critchley HO, Warner P, Lee AJ. Evaluation of abnormal uterine bleeding: comparison of 3 outpatient procedures within cohorts defined by age and menopausal status. Health Technol Assess 2001;8:iii-iv, 1-139.
26 National Institute for Health and Care Excellence. Heavy menstrual bleeding: investigation and management. CG44. 2007.
www.nice.org.uk/CG44.
27 ESHRE Capri Workshop Group. Endometrial bleeding. Hum Reprod Update 2007;13:421-31.
28 Lumsden MA. Modern management of fibroids. Obstet Gynaecol Reprod Med2009;20:82-6.
29 Donnez J, Tatarchuk T, Bouchard P, Puscasiu L, Zakharenko N, Ivanova T, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012;366:409-20.
30 Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolisation for uterine fibroids. Cochrane Database Syst Rev 2012;5:CD005073.
For personal use only: See rights and reprints
http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe BMJ 2013;346:f3251 doi: 10.1136/bmj.f3251 (Published 4 June 2013) Page 5 of 10
31 National Institute for Health and Care Excellence. Long-acting reversible contraception. CG30. 2005.
www.nice.org.uk/CG030. For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe BMJ 2013;346:f3251 doi: 10.1136/bmj.f3251 (Published 4 June 2013) Page 6 of 10
32 Abdel-Aleem H, d’Arcangues C, Vogelsong K, Gulmezoglu AM. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 2007;4:CD003449.
33 Hickey M, Higham H, Fraser I. Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation. Cochrane Database Syst Rev 2012;9:CD001895.
34 Orbo A, Arnes M, Hancke C, Vereide AB, Pettersen I, Larsen K. Treatment results of endometrial hyperplasia after prospective D-score classification—a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol2008;111:68-73.
35 WHO. Selective practice recommendations for contraceptive use. 2nd ed. 2004. Updated 2008.
www.who.int/reproductivehealth/publications/family_planning/9241562846index/en/index.html
 

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

 
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2017